Anbio Biotechnology NNNN
NASDAQ NNNN
$6.54 -0.06 (-0.91%)
At close: Sep 4, 2026 · 4:00 PM EDT

Anbio Biotechnology (NNNN) Market Capitalization (2025)

Anbio Biotechnology (NNNN) posted Market Capitalization of $4.3 billion for Q4 2025, down 3.95% on a QoQ basis from $4.5 billion in Q2 2025.

Analysis

Anbio Biotechnology (NNNN) Market Capitalization (2025) Analysis & Trends

Anbio Biotechnology has reported Market Capitalization for 1 years, with the latest figure at $4.3 billion in Q4 2025.

  • On a quarterly basis, Market Capitalization changed N/A year-over-year to $4.3 billion in Q4 2025; TTM through Dec 2025 was $4.3 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $4.3 billion, changed N/A from the prior year.
  • Market Capitalization was $4.3 billion for Q4 2025 at Anbio Biotechnology, down from $4.5 billion in the prior quarter.
  • The five-year high for Market Capitalization was $4.5 billion in Q2 2025, with the low at $4.3 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 31.10 Bn 29.22 Bn 2.18 Bn
2 Lantheus Holdings 6.59 Bn 6.00 Bn 241.86 Mn
3 Heartflow 4.24 Bn 3.87 Bn 53.19 Mn
4 Neogen 2.58 Bn 2.39 Bn 107.80 Mn
5 Butterfly Network 1.75 Bn 1.62 Bn 23.29 Mn
6 QuidelOrtho 954.15 Mn 830.75 Mn -
7 Ceribell 944.88 Mn 815.62 Mn 25.94 Mn
8 Anbio Biotechnology 941.05 Mn 929.15 Mn -
9 Varex Imaging 780.16 Mn 694.86 Mn 76.70 Mn
10 Prenetics Global 357.49 Mn 298.35 Mn 30.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.33 Bn
Jun 30, 2025 4.50 Bn